# Value analysis committee: how hospitals approve new products, and how suppliers get through

What a hospital value analysis committee is, who sits on it, what evidence it asks for and why a clinician has to submit your product, drawn from published hospital policies.

By Supreet Gupta, Co-founder and Chief Product Officer, Dmand AI · Published 2026-10-19

Read on the web: https://dmand.ai/blog/value-analysis-committee

**Short answer**

A value analysis committee is the group that decides whether a hospital adopts a new medical product. It reviews clinical evidence, cost and outcomes, and its members usually include supply chain, physicians, nurses and finance. Suppliers usually cannot submit a product themselves: a clinician sponsor files the request, and the supplier provides the evidence.

Most guides to the value analysis committee are written for the people who run one. This one is for suppliers. It is built from published hospital policies, so the rules, forms and timelines below come from real hospitals, not opinion.

## What a value analysis committee is in a hospital

A hospital value analysis committee, often shortened to VAC, decides which medical products the hospital adopts and which ones it standardizes on. Corewell Health describes its value analysis program as a systematic, objective, evidence-based process to evaluate current and developing technologies, with the aim of managing expense while keeping safety and quality.[1]

In a peer-reviewed column, a co-chair of the orthopaedic value analysis committee at Northwestern Medicine, an 11-hospital system, describes the main job as adopting and standardizing products, and notes that committees have grown in importance as payment shifts from fee-for-service toward value-based care.[2]

The profession has its own bodies. The Association of Healthcare Value Analysis Professionals (AHVAP) runs the CVAHP certification for value analysts, and AHRMM's Cost, Quality and Outcomes movement treats the three as one equation.[3][4]

## Who sits on a hospital value analysis committee

Membership changes by hospital and by product category, but most committees draw from the same groups.

- **Value analysis and supply chain.** The value analysis director or analysts run the process, and supply chain brings pricing, contracts and cost comparisons.
- **Physicians.** Usually a physician lead for the specialty, and the surgeons or proceduralists who would use the product.
- **Nursing.** Nurse leaders from the units where the product is used.
- **Finance.** Budget and reimbursement impact.
- **Specialists as needed.** Quality, infection prevention, clinical engineering and IT join when the product touches their area.

Health systems often split the work. CentraCare runs ten category committees, such as surgical, imaging, laboratory and advanced wound care, under a value analysis steering committee.[5] In a 2024 survey of value analysis leaders by GHX and AHVAP (co-funded by GHX, a supply chain software vendor), about 58% of respondents worked in [IDNs](https://dmand.ai/glossary/integrated-delivery-network-idn).[6]

## What a value analysis committee looks at: cost, quality and outcomes

A committee asks whether a new product delivers more value than what the hospital uses today. The Northwestern Medicine co-chair sums it up as quality divided by cost.[2]

In practice that means four questions:

1. **Is it safe and does it work?** Clinical evidence, ideally independent of the manufacturer.
2. **What does it cost, all in?** Price per unit, per procedure and per year, against the current product.
3. **Will we be paid for it?** Reimbursement, and the effect on the hospital's margin.
4. **What else changes?** Training, workflow, storage, IT connections and whether it replaces a product or adds one.

Legacy Health's policy, for example, lists established reimbursement and a neutral or positive margin among its approval criteria.[7]

## How a new product request reaches the value analysis committee, step by step

The steps differ by hospital, but most published policies follow the same order. The University of Arkansas for Medical Sciences (UAMS) is a clear example.[8]

1. **A clinician sponsors the request** At UAMS, since May 13, 2024, a UAMS clinician starts every new product or trial request with a 10-question short form.
2. **The supplier completes its part** The vendor rep then fills in a longer form with product, evidence and pricing details.
3. **Value analysis adds the numbers** The value analysis team projects the financial impact for the hospital.
4. **The sponsor presents** The clinician sponsor presents the request at the monthly Value Analysis Committee meeting.
5. **The committee votes** The committee approves, denies or asks for a trial or more information.

## Why a sales rep cannot submit a value analysis request without a clinician sponsor

The most important rule in hospital value analysis is that the request has to come from inside the hospital.

At the University of Utah Health, the physician champion must submit requests for surgical areas, and other areas need a clinical sponsor.[9] Covenant HealthCare in Michigan goes further: its policy says vendor reps may not complete or submit requests.[10]

So the first job is not the committee. It is finding a physician or nurse leader who has the problem your product solves and will put their name on the request. Without a sponsor, the best evidence packet never reaches the agenda.

> **Find two sponsors, not one**
>
> A request with a physician sponsor and a nurse leader who supports it carries more weight, and it survives if one of them changes roles before the vote.

## What evidence a value analysis committee asks suppliers for

Hospitals publish what they want to see. Put together, these policies describe the packet a supplier should have ready before a sponsor files.

**The value analysis packet**

- The FDA clearance or approval letter (HonorHealth asks for it with every request)
- Clinical evidence, preferably not produced by the manufacturer (Covenant HealthCare's preference)
- A cost comparison against the product the hospital uses today
- Reimbursement codes and the expected effect on margin
- For connected devices, how the product stores and sends patient data, for IT review
- For equipment, specifications for clinical engineering review
- A trial plan, if the committee wants to test the product first

HonorHealth asks for a request form, clinical or financial evidence and the FDA approval letter, and Legacy Health sends products that touch patient data or interfaces to its Information Services team for review.[11][7]

## How long hospital value analysis takes, from request to vote

Expect weeks to months. Most committees meet monthly, so a request that misses one meeting waits for the next.

Covenant HealthCare asks for at least 21 business days before review. It sends new technology or products with high financial impact, defined as $500 or more added per procedure or $25,000 or more added per year, to a monthly advisory council, and it scores requests on a 0 to 27 scale.[10]

A denial can be expensive. Covenant will not review a denied request again for one year unless new evidence appears.[10] Get the packet right the first time.

## Value analysis in a health system: system committees vs hospital committees

In a health system, the committee that decides may sit above the hospital you are calling. Northwestern Medicine runs a system-level orthopaedic committee across its 11 hospitals, and CentraCare runs its category committees for the whole system.[2][5]

That changes the work. You need a sponsor at a hospital that uses the product, and you need to know which system committee reviews your category and when it meets. A product approved at the system level can open every hospital in the system at once.

See [how to find out who owns a hospital](https://dmand.ai/blog/who-owns-a-hospital) to map which hospitals sit under which system.

## Which purchases go to value analysis and which go to IT, capital or P&T committees

Value analysis is not the only gate. Large hospitals send different purchases to different committees, and a product can need more than one.

| What is being bought | Usual committee | What it checks |
| --- | --- | --- |
| Medical and surgical supplies, implants, devices | Value analysis committee | Evidence, cost, standardization |
| New high-cost technology | Technology assessment committee or advisory council | Clinical value, strategic fit, financial impact |
| Drugs | Pharmacy and therapeutics (P&T) committee | Formulary fit, safety, cost |
| Software and connected systems | IT governance and security review | Data handling, interfaces, support |
| Large equipment | Capital committee, with clinical engineering | Budget, capital priority, maintenance |

*Which committee usually reviews what. Names and splits vary by hospital.*

Source: Published hospital policies (CentraCare, Legacy Health, Covenant HealthCare)

CentraCare, for example, runs a Medical Technology Assessment Committee and a P&T committee alongside its value analysis committees.[5] For how capital and IT purchases move, see [how hospitals buy, by purchase type](https://dmand.ai/blog/selling-to-hospitals).

## How value analysis approval and GPO contracts fit together

A [GPO](https://dmand.ai/glossary/group-purchasing-organization-gpo) contract and a value analysis approval answer different questions. The GPO contract sets the price and terms a member hospital can buy at. Value analysis decides whether the hospital's clinicians may use the product at all.

Being on contract helps, because supply chain does not have to negotiate a new agreement. But it does not get a product past the committee. Read [how GPO contracts work for hospital suppliers](https://dmand.ai/blog/gpo-contracts) for the other half.

## Value analysis rules that can get a supplier blocked

Hospitals enforce value analysis with conduct rules for reps, and breaking one can cost you the account.

- **No samples or in-services without approval.** HonorHealth does not let reps leave samples or run in-services without authorization.[11]
- **No purchase order, no payment.** HonorHealth will not issue a purchase order without value analysis approval, and CentraCare does not pay for products introduced without approval.[11][5]
- **No going around the process.** Reps who push a product straight to a clinician or a unit can be barred from the facility.

> **Read the supplier policy before the first visit**
>
> Most hospitals post their supplier rules and value analysis policy on a supplier or vendor page. Read it before you contact a clinician, and follow the credentialing steps it lists.

## How to find the value analysis team at a target hospital

Before you look for a sponsor, map the people who run the process at the hospital and at its parent system.

1. **Check the supplier page.** Many hospitals publish their value analysis process and contact on it.
2. **Find the parent system.** If the hospital belongs to a health system, the committee for your category may sit at the system level.
3. **Find the value analysis and supply chain leaders.** The director of value analysis, the analysts and the VP of supply chain run the process.
4. **Find possible sponsors.** The department chair, the physician lead for the specialty and the nurse leaders on the units that would use your product.
5. **Check how to reach them.** Get a working email and direct dial, and look for a colleague or customer who knows them.

Dmand AI maps 1.6K+ health systems and IDNs down to 997K+ sites of care, with 11M+ healthcare executives and 7.4M+ HCPs attached to the site where they work, so you can see the supply chain leaders and the clinicians at the same hospital in one view.

**Find the value analysis and supply chain leaders at your target hospital**

Open any hospital or health system, see the supply chain, value analysis and clinical leaders at each site, and get their contact details. 30 days free, self-serve, no credit card.

[Start free trial](https://app.dmand.ai/signup) · [Book a demo](https://dmand.ai/book-a-demo)

## Sources

1. [Value Analysis Program](https://corewellhealth.org/suppliers/value-analysis-program), Corewell Health
2. [Value-based healthcare: controlling costs through a value analysis committee](https://pubmed.ncbi.nlm.nih.gov/38547476/), Kalainov DM, Clinical Orthopaedics and Related Research, 2024
3. [Committees](https://www.ahvap.org/committees), Association of Healthcare Value Analysis Professionals
4. [What is CQO?](https://www.ahrmm.org/node/212259), AHRMM, American Hospital Association
5. [Value analysis for vendors](https://www.centracare.com/for-vendors/value-analysis/), CentraCare
6. [Healthcare Value Analysis Today and Tomorrow](https://www.ghx.com/media/lmsnganx/ghx_ahvap_whitepaper_0525_update.pdf), AHVAP and GHX, 2024
7. [New Supply and Equipment Procurement Policy](https://www.legacyhealth.org/-/media/Files/PDF/Doing-Business-With-Us/Doing-business-with/NewSupplyandEquipmentProcurement.pdf), Legacy Health
8. [Value Analysis Product Request](https://supplychain.uams.edu/value-analysis/product-request/), UAMS Supply Chain
9. [New products](https://uofuhealth.utah.edu/supply-chain/new-products), University of Utah Health Supply Chain
10. [Clinical Quality Product Value Analysis Policy](https://www.covenanthealthcare.com/Uploads/Public/Documents/Workfiles/CQPVA/2022-CQPVA-Policy.pdf), Covenant HealthCare
11. [Introduction of medical and surgical products](https://www.honorhealth.com/sites/default/files/documents/company/introduction-of-medical-and-surgical-products.pdf), HonorHealth

## Questions suppliers ask about value analysis committees

### What is a value analysis committee in a hospital?

A value analysis committee is the group that decides whether a hospital or health system adopts a new medical product or keeps an existing one. It weighs clinical evidence, cost and outcomes, and its members usually include supply chain, physicians, nurses and finance.

### Who sits on a hospital value analysis committee?

Usually a value analysis or supply chain lead, physician and nurse representatives from the clinical areas involved, and finance. Quality, infection prevention, clinical engineering and IT join when the product touches their area. Health systems often run separate committees by specialty or product category.

### Can a sales rep submit a product to a value analysis committee?

Usually not. Published policies at hospitals such as UAMS and the University of Utah Health require a clinician sponsor to start the request, and Covenant HealthCare's policy bars vendor reps from completing or submitting requests. The rep supplies the evidence the sponsor and committee ask for.

### How long does hospital value analysis take?

Weeks to months. Most committees meet monthly, and some set a minimum lead time: Covenant HealthCare asks for at least 21 business days before review. A trial adds time, and some hospitals will not review a denied product again for a year without new evidence.

### What evidence does a value analysis committee want from suppliers?

Expect to provide the FDA clearance or approval letter, clinical evidence that is preferably independent of the manufacturer, a cost comparison against the product used today, reimbursement and margin impact, and, for connected devices or equipment, IT and clinical engineering information.

### Does a GPO contract mean a hospital will buy my product?

No. A GPO contract sets price and terms that member hospitals can use, but each hospital or health system still decides through its own value analysis process whether clinicians may use the product.

### What is the difference between value analysis and a P&T committee?

A value analysis committee reviews medical supplies, devices and often equipment. A pharmacy and therapeutics (P&T) committee reviews drugs for the hospital formulary. New high-cost technology may go to a separate technology assessment committee, and software usually goes to IT governance.

### How do I find the value analysis team at a hospital?

Start with the hospital's supplier or vendor page, which often names the value analysis process and contact. Then look at the parent health system, since many systems run value analysis centrally, and identify the clinical department leaders who could sponsor your product.